NCT02083419

Brief Summary

Cardiac resynchronization therapy (CRT) or biventricular pacing is a useful treatment for heart failure and those suffering from arrhythmias. The purpose of this research study is to determine the effect left-ventricular pacing has on patients who have a ventricular assist device.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2014

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 4, 2014

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 11, 2014

Completed
2 months until next milestone

Study Start

First participant enrolled

April 28, 2014

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 2, 2017

Completed
Last Updated

February 8, 2017

Status Verified

February 1, 2017

Enrollment Period

2.7 years

First QC Date

March 4, 2014

Last Update Submit

February 7, 2017

Conditions

Keywords

Left Ventricular Assist Devices (LVAD)Cardiac Resynchronization Devices (CRT)

Outcome Measures

Primary Outcomes (4)

  • Change in echocardiographic parameters

    A comparison of the echocardiogram completed at enrollment and at 30 days.

    Change in baseline to 30 days

  • 6 minute walk distance

    A trained staff member will supervise participants in the completion of a 6 minute walk test. They will be instructed to walk on a level surface, on a clearly marked indoor course. heart rate and oxygen level will be monitored. The total distance completed at the end of 6 minutes will be noted.

    Change in baseline to 30 days

  • Quality of Life

    A comparison of the questionnaires completed at enrollment and at 30 days.

    Change in baseline to 30 days

  • Number of Ventricular Tachycardia Episodes

    At baseline and again at 30 days CRT device interrogation will be done to count the number of ventricular tachycardia episodes with LV pacing on and off.

    Change in baseline to 30 days

Study Arms (1)

LVAD CRT

The following procedures will be performed: limited echocardiogram, an adjustment to the CRT device's programmed settings, follow-up in 30 days to adjust the CRT device's programmed settings. In addition, quality of life questionnaires will be filled out and a 6 minute walk test will be completed.

Device: LVAD CRT

Interventions

LVAD CRTDEVICE

The following procedures will be performed: limited echocardiogram, an adjustment to the CRT device's programmed settings, follow-up in 30 days to adjust the CRT device's programmed settings. In addition, quality of life questionnaires will be filled out and a 6 minute walk test will be completed.

LVAD CRT

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults with ventricular dysfunction, dyssynchrony, functional capacity presence of arrhythmia. LVAD patients undergo 6 minute walk testing and complete a quality of life questionnaire routinely as part of their care on our LVAD clinic. Additionally, periodic echcoardiography is obtained to determine LVAD dynamics and ventrocular dimensions. We will utilize this information for our study, as well as information from their cardiac resynchronization devices, which is part of routine care for patietns with pacemakers and defibrillators.

You may qualify if:

  • Presence of LVAD support and CRT device with working LV lead in patients \> 18years of age
  • Left ventricular pacing at time of enrollment

You may not qualify if:

  • LV lead dysfunction
  • Prior AV node ablation
  • Presence of total heart block
  • Presence of significant bradycardia/lack of underlying rhythm
  • Inability to complete 6 minute walk test
  • Inability to return to clinic for repeat assessment
  • Any LVAD programmed speed change within the prior 30 days
  • Any CRT programming changes within the prior 30 days

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Florida

Gainesville, Florida, 32610, United States

Location

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Officials

  • Mustafa Ahmed, MD

    University of Florida

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 4, 2014

First Posted

March 11, 2014

Study Start

April 28, 2014

Primary Completion

January 1, 2017

Study Completion

February 2, 2017

Last Updated

February 8, 2017

Record last verified: 2017-02

Locations